Selamectin Is the Avermectin with the Best Potential for Buruli Ulcer Treatment

In-vitro Activity of Avermectins against Mycobacterium ulcerans

(2015) Till F. Omansen et al.   PLoS Neglected Tropical Diseases

Recent advances in biochemistry and biotechnological synthesis of avermectins and their derivatives

(2014) Nguyen Huy Thuan et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Measurements of the in vitro anti-mycobacterial activity of ivermectin are method-dependent

(2014) S. Ramon-Garcia et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

An LC-MS Method for Determination of Milbemycin Oxime in Dog Plasma

(2013) Q. Xu et al.   JOURNAL OF CHROMATOGRAPHIC SCIENCE

Anthelmintic Avermectins Kill Mycobacterium tuberculosis, Including Multidrug-Resistant Clinical Strains

(2012) L. E. Lim et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics of spinosad and milbemycin oxime administered in combination and separately per os to dogs

(2011) S. D. HOLMSTROM et al.   JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS

Role of P-Glycoprotein in the Disposition of Macrocyclic Lactones: A Comparison between Ivermectin, Eprinomectin, and Moxidectin in Mice

(2010) S. Kiki-Mvouaka et al.   DRUG METABOLISM AND DISPOSITION

Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial

(2010) Willemien A Nienhuis et al.   LANCET

The Pharmacokinetics and Interactions of Ivermectin in Humans—A Mini-review

(2008) Aránzazu González Canga et al.   AAPS Journal

Brain penetration of ivermectin and selamectin inmdr1a,bP-glycoprotein- andbcrp- deficient knockout mice

(2008) J. GEYER et al.   JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS